Skip to main content
. 2017 Aug 28;2(1):e000121. doi: 10.1136/tsaco-2017-000121

Table 3.

Summary of the two-biomarker model for diagnosis of ARDS in the derivation cohort

Biomarker
(upper and lower quartiles)
OR for ARDS* 95% CI p
RAGE (1846 vs 656) 2.382 1.638 to 3.464 <0.001
Ang-2 (6128 vs 2935) 1.890 1.322 to 2.702 <0.001

*OR for ARDS comparing upper quartile (75th percentile) to lower quartile (25th percentile).

Ang-2, angiopoietin-2; ARDS, acute respiratory distress syndrome; RAGE, receptor for advanced glycation endproducts.